Full-Thickness Retinochoroidal Incision in the Management of Central Retinal Vein Occlusion

Table 1

Demographic data of patients.

	Perfusion statue	Duration of symptoms (months)	Preoperative Snellen BCVA	Postoperative Snellen BCVA	Preoperative CMT (μm)	Postoperative CMT (μm)	Number of RCVA formation	Complication
1/F/75	I	3	1/20	4/200	277	213	1	None
2/M/58	I	4	HM	4/200	388	93	1	VH + NVG
3/M/60	I	6	4/200	4/200	445	138	2	None
4/F/72	I	10	4/200	4/200	309	182	1	None
5/F/63	N	4	4/20	8/20	502	381	2	None
6/F/74	I	5	4/200	4/200	753	229	1	VH
7/F/45	I	5	4/200	4/200	358	283	2	None
8/M/58	I	4	4/200	1/20	409	343	1	None
9/F/41	I	4	1/20	1/20	328	148	2	None
10/F/63	N	9	4/200	4/200	392	201	2	None
11/F/50	N	4	1/20	10/20	409	230	2	None
12/F/59	N	6	1/20	6/20	574	325	1	None
13/M/73	I	3	2/20	4/200	749	160	3	VH
14/M/66	I	3	2/200	2/200	562	202	1	VH + PFM
15/F/73	N	3	2/20	16/20	414	225	1	None
16/M/62	I	4	4/200	4/200	380	182	2	PFM
17/M/71	I	4	4/200	4/200	772	169	2	VH + NVG
18/M/46	N	3	2/20	6/20	535	444	3	None
19/M/47	N	3	1/20	8/20	802	305	2	None
20/M/85	N	15	4/200	4/200	464	199	2	None
21/M/76	N	5	4/200	4/200	599	355	2	None
22/M/70	N	3	4/200	4/200	527	189	1	None
23/M/62	I	11	4/200	4/200	385	224	2	PFM
24/F/68	I	8	1/20	1/20	476	198	2	None
25/F/53	N	3	2/20	10/20	492	172	2	None
26/M/58	N	3	2/20	20/20	581	168	1	None
27/M/62	N	1	2/20	18/20	626	352	2	None
28/F/57	N	3	4/20	10/20	427	344	2	None

BCVA: best corrected visual acuity, HM: hand motion, CMT: central macular thickness, RCVA: retinochoroidal venous anastomosis, VH: vitreous hemorrhage, NVG: neovascular glaucoma, and PFM: preretinal fibrovascular membrane.